Red flags / Dilution

HSCSHeartSciences Inc.ElevatedForm 424B5filed Nov 19, 9:18 AM ET

HeartSciences files to sell up to $3.08 million of common stock through Maxim ATM program

HeartSciences filed a prospectus supplement dated November 19, 2026 for an at-the-market equity program with Maxim Group, allowing sales of common stock of up to $3,077,649 under the equity distribution agreement dated November 18, 2026. The company states Maxim receives a 2.5% commission while it remains subject to Form S-3 General Instruction I.B.6 limits, and that about $4.3 million was already sold under that rule in the prior 12 months. The filing also notes the non-affiliate float is $22.9 million and that a pending merger with Fortitude Mining is expected to close in Q4 2026, which can matter because ongoing dilution from share sales adds supply to the stock during a major transaction.

“In accordance with the terms of the Equity Distribution Agreement, we may offer and sell shares of our common stock having an offering price of up to $3,077,649, subject to General Instruction I.B.6 of Form S-3 and an aggregate offering price of up to $50,000,000 from time to time through Maxim, acting as our agent or principal.”

What the stock did

From the last close before the filing was public. Market cap now: $10M.

1 day
-3.3%
SPY -2.0%
5 days
Not yet
 
20 days
Not yet
 

Prospectus supplement or shelf for new shares, including at-the-market programs. Flags are a screen for filings worth reading, not advice. Read the filing before acting on it.

Other flags on HSCS

FiledStockFlagWhat the filing saysMkt cap5 days20 days
Sep 25, 5:00 PM ETHSCS
HeartSciences Inc.
Dilution
WatchForm S-3
HeartSciences Inc. filed a new S-3 shelf registration$10M-9.1%-33.6%
Sep 14, 4:14 PM ETHSCS
HeartSciences Inc.
Material weakness
ElevatedForm 10-Q
HeartSciences says disclosure controls were not effective at July 31, 2026 due to material weaknesses$10M+32.2%-6.8%
Sep 14, 4:14 PM ETHSCS
HeartSciences Inc.
Going concern
ElevatedForm 10-Q
HeartSciences flags substantial doubt about going concern as losses and stockholders' deficit mount$10M+32.2%-6.8%